Insulet Sustainability Profile
Insulet Corporation, commonly known for its innovative Omnipod® Insulin Management System, is a leading player in the diabetes care industry. Headquartered in the United States, Insulet operates primarily in North America and Europe, focusing on developing advanced insulin delivery solutions. Founded in 2000, the company has achieved significant milestones, including the launch of its tubeless insulin pump, which revolutionised diabetes management for many patients. Insulet's core product, the Omnipod, stands out due to its unique design that offers a wireless, waterproof, and discreet insulin delivery system. This innovative approach has positioned Insulet as a market leader, recognised for enhancing the quality of life for individuals with diabetes. With a commitment to continuous improvement and patient-centric solutions, Insulet remains at the forefront of diabetes technology, driving advancements that empower users to manage their condition effectively.
DitchCarbon Score
How does Insulet's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Insulet's score of 39 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Insulet's reported carbon emissions
In 2024, Insulet Corporation reported total emissions of approximately 13,500,000 kg CO2e, comprising 1,383,000 kg CO2e from Scope 1 and 11,467,000 kg CO2e from Scope 2 emissions. The company has set ambitious climate commitments, aiming for a net-zero transition by 2050, with specific targets for both Scope 1 and Scope 2 emissions established for the near term (2023-2030). Notably, Insulet achieved a reduction of approximately 19% in Scope 1 emissions from 2020 to 2021, demonstrating its commitment to decreasing greenhouse gas emissions. The company is also investing in renewable energy initiatives, particularly in its new manufacturing facility in Malaysia, which is on track for Green Building Index (GBI) and Leadership in Energy and Environmental Design (LEED) Silver certifications. Insulet's emissions data is not cascaded from any parent organization, indicating that the reported figures are solely from its own operations. The company continues to develop its blueprint for achieving net-zero emissions, reinforcing its dedication to sustainability and environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 1,709,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,761,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
How Carbon Intensive is Insulet's Industry?
How Carbon Intensive is Insulet's Location?
Insulet's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Insulet has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Siemens Healthineers AG
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.